5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B plays an important role in the regulation of behavior, including impulsive behavior. It protects cardiomyocytes against apoptosis and plays a role in the adaptation of pulmonary arteries to chronic hypoxia and vasoconstriction.
The 5-HT2B pipeline market research report provides comprehensive information on the 5-HT2B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research, and development history as well as the latest news and press releases. Additionally, the report provides an overview of key players involved in 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics development with respective active and dormant or discontinued projects.
Key Therapy Areas in the 5-HT2B Pipeline Products Market
The key therapy areas in the 5-HT2B pipeline products market are the central nervous system, cardiovascular, gastrointestinal, musculoskeletal disorders, respiratory, immunology, and ophthalmology.
5-HT2B Pipeline Products Market Analysis by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanisms of Action in the 5-HT2B Pipeline Products Market
The key mechanism of action in the 5-HT2B pipeline products market is the 5-Hydroxytryptamine Receptor 2B Antagonist.
Key Routes of Administration in the 5-HT2B Pipeline Products Market
The key route of administration in the 5-HT2B pipeline products market is oral.
Key Molecule Types in the 5-HT2B Pipeline Products Market
The key molecule type in the 5-HT2B pipeline products market is small molecule.
Major Companies in the 5-HT2B Pipeline Products Market
The major companies in the 5-HT2B pipeline products market are AnaMar AB, Daya Drug Discoveries Inc, Neurim Pharmaceuticals Ltd, RaQualia Pharma Inc, and Reviva Pharmaceuticals Inc.
5-HT2B Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
5-HT2B Pipeline Products Market Report Overview
Key Therapy Areas | Central Nervous System, Cardiovascular, Gastrointestinal, Musculoskeletal Disorders, Respiratory, Immunology, and Ophthalmology |
Key Mechanisms of Action | 5-Hydroxytryptamine Receptor 2B Antagonist |
Key Routes of Administration | Oral |
Key Molecule Type | Small Molecule |
Major Companies | AnaMar AB, Daya Drug Discoveries Inc, Neurim Pharmaceuticals Ltd, RaQualia Pharma Inc, and Reviva Pharmaceuticals Inc |
Scope
- The report provides a snapshot of the global therapeutic landscape for 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B)
- The report reviews 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics and enlists all their major and minor projects
- The report assesses 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding the 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Daya Drug Discoveries Inc
Neurim Pharmaceuticals Ltd
RaQualia Pharma Inc
Reviva Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the 5-HT2B pipeline products market?
The key therapy areas in the 5-HT2B pipeline products market are the central nervous system, cardiovascular, gastrointestinal, musculoskeletal disorders, respiratory, immunology, and ophthalmology.
-
What are the key mechanisms of action in the 5-HT2B pipeline products market?
The key mechanism of action in the 5-HT2B pipeline products market is the 5-Hydroxytryptamine Receptor 2B Antagonist.
-
What are the key routes of administration in the 5-HT2B pipeline products market?
The key route of administration in the 5-HT2B pipeline products market is oral.
-
What are the key molecule types in the 5-HT2B pipeline products market?
The key molecule type in the 5-HT2B pipeline products market is small molecule.
-
Which are the major companies in the 5-HT2B pipeline products market?
The major companies in the 5-HT2B pipeline products market are AnaMar AB, Daya Drug Discoveries Inc, Neurim Pharmaceuticals Ltd, RaQualia Pharma Inc, and Reviva Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.